Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, April 05, 2017
Sharp Clinical Services, part of UDG Healthcare plc, has announced a £9 million investment to fund a new multiple-phase pharmaceutical manufacturing, packaging and distribution facility in Wales.
read more
Monday, February 11, 2019
Sharp has announced a $650,000 investment into enhancing its Interactive Response Technology (IRT) solution.
read more
Sharp, part of UDG Healthcare plc, has acquired a pharmaceutical packaging facility from Quality Packaging Specialists International (QPSI).
read more
Thursday, October 05, 2023
Sharp, a provider of commercial pharmaceutical packaging and clinical trial supply services, has announced the acquisition of Berkshire Sterile Manufacturing (BSM), a Massachusetts-based fill finish contract development and manufacturing organization...
read more
Wednesday, August 07, 2024
Governor Josh Shapiro announced the Commonwealth is investing nearly $3 million in Adare Pharma Solutions to support the life sciences company’s growth and headquarters relocation to Pennsylvania from New Jersey. Within three years, Adare’s $16.8 ...
read more
Tuesday, October 10, 2017
ShangPharma and SRI announced a collaboration to accelerate the development of innovative pharmaceuticals targeting neuroinflammation.
read more
SPII is providing funding and other support to scientists at UCSF to accelerate the development of science inventions.
read more
ShangPharma, a life science partnering organization providing drug development and discovery services, technology, and investment for the pharmaceutical and biotechnology industry, announced the intent for a strategic corporate restructuring.
read more
Wednesday, February 07, 2018
Biostar Pharmaceuticals announced its variable interest entity in China, Shaanxi Aoxing Pharmaceutical, has renewed its GMP certificate and Pharmaceutical Production License.
read more
SGS has received approval from FAMHP and has initiated the first site to begin a new clinical trial of a potential treatment for patients with COVID-19 related respiratory failure.
read more
Thursday, October 12, 2017
SGS has entered into collaboration with Bavarian Nordic A/S, an international biotechnology company specializing in vaccines, to develop a new respiratory syncytial virus (RSV) challenge strain.
read more
Wednesday, December 09, 2020
SGS has announced the recruitment of the first participants in the US who will be taking part in a multinational clinical trial of a potential drug candidate for those suffering with COVID-19 related respiratory failure.
read more
SGS announced it is expanding its biopharmaceutical testing capabilities in Geneva, Switzerland with a new 200m2 laboratory.
read more
Wednesday, September 05, 2018
SGS has successfully implemented advanced techniques for the collection and use of PBMCs for early phase clinical trials at its Clinical Pharmacology Unit in Antwerp, Belgium.
read more
Monday, December 10, 2018
SGS is investing €3.5 million to undertake a two-phase expansion project at its laboratory in Poitiers, France, to implement a 50% increase in bioanalytical capabilities at the site by 2020.
read more